Proto Labs Inc (PRLB) — Cash Flow-to-Debt Ratio
Proto Labs Inc (PRLB) has a Cash Flow-to-Debt Ratio of 0.18x as of March 2026, meaning its operating cash flow of $17.54 Million could theoretically repay 0% of its total liabilities ($95.44 Million) in one year. See PRLB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Proto Labs Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Proto Labs Inc across 17 annual periods. Also explore Proto Labs Inc (PRLB) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Proto Labs Inc (2009–2025)
Year-by-year debt coverage analysis for Proto Labs Inc. For market capitalisation and broader financial context, see PRLB stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.83x | $74.50 Million | $89.48 Million | ▼ -21.5% |
| 2024 | 1.06x | $77.83 Million | $73.36 Million | ▲ +11.6% |
| 2023 | 0.95x | $73.27 Million | $77.06 Million | ▲ +60.1% |
| 2022 | 0.59x | $62.08 Million | $104.52 Million | ▲ +7.6% |
| 2021 | 0.55x | $55.24 Million | $100.09 Million | ▼ -48.5% |
| 2020 | 1.07x | $106.97 Million | $99.85 Million | ▼ -18.9% |
| 2019 | 1.32x | $116.05 Million | $87.88 Million | ▼ -16.8% |
| 2018 | 1.59x | $122.93 Million | $77.49 Million | ▲ +9.0% |
| 2017 | 1.46x | $81.75 Million | $56.15 Million | ▼ -33.2% |
| 2016 | 2.18x | $74.97 Million | $34.41 Million | ▲ +24.2% |
| 2015 | 1.75x | $58.56 Million | $33.39 Million | ▼ -32.6% |
| 2014 | 2.60x | $57.21 Million | $21.98 Million | ▼ -0.4% |
| 2013 | 2.61x | $48.44 Million | $18.53 Million | ▲ +78.0% |
| 2012 | 1.47x | $25.31 Million | $17.23 Million | ▼ -2.2% |
| 2011 | 1.50x | $23.54 Million | $15.68 Million | ▲ +697.7% |
| 2010 | 0.19x | $14.01 Million | $74.44 Million | ▲ +61.1% |
| 2009 | 0.12x | $8.39 Million | $71.83 Million | — |